Covid-19 Patients Clinical Trial
— TA/SARS-Cov2Official title:
Is Adipose Tissue a Reservoir for SARS-Cov2 Spread?
Resident cells of human adipose tissue express ACE2 and DPP4, receptors for SARS-Cov2. The hypothesis is that the virus may enter and spread in fat depots.
| Status | Not yet recruiting |
| Enrollment | 5 |
| Est. completion date | July 9, 2021 |
| Est. primary completion date | July 9, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Male or female = 18 years old - Patients testing positive for Covid19 - Patients affiliated to social security - Signing of free and informed consent Exclusion Criteria: - Vulnerable persons (- minors, - adults under guardianship or curatorship, - pregnant women, - persons deprived of their liberty, - persons who do not master the French language) |
| Country | Name | City | State |
|---|---|---|---|
| France | CHU de Nice | Nice |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Universitaire de Nice |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The presence of SARS-CoV2 in adipose tissue of Covid19 patients | RT-qPCR for SARS-Cov-2 from RNAs and by immunodetection | Day 0 | |
| Secondary | The expression of inflammatory cytokines in adipose tissue of Covid19 patients | RT-qPCR for IL6 | Day 0 | |
| Secondary | The expression of inflammatory cytokines in adipose tissue of Covid19 patients | RT-qPCR for IL1 | Day 0 | |
| Secondary | The expression of inflammatory cytokines in adipose tissue of Covid19 patients | RT-qPCR for TNFa | Day 0 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04592835 -
To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
|
Phase 1 | |
| Not yet recruiting |
NCT05083104 -
Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
|
||
| Completed |
NCT05162534 -
Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
|
||
| Completed |
NCT04853979 -
Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure
|
N/A | |
| Completed |
NCT05369676 -
To Evaluate SSD8432/ Ritonavir in Adults With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT05901337 -
Cupping Therapy on Immune System in Post Covid -19
|
N/A | |
| Recruiting |
NCT06349720 -
Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
|
||
| Completed |
NCT04407130 -
Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.
|
Phase 2 | |
| Terminated |
NCT04541485 -
To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)
|
Phase 1 | |
| Withdrawn |
NCT04374903 -
Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients
|
N/A |